Indication
Proteus meningitis
Proteus meningitis is a severe, uncommon bacterial infection of the central nervous system characterized by inflammation of the meninges and spinal cord due to species of the gram-negative bacillary genus *Proteus*, most frequently *Proteus mirabilis*. Read more about Proteus meningitis
16 drugs 14 manufacturers
Drugs that treat it
Common Proteus meningitis therapies.
AMIKACIN (amikacin sulfate)
AMIKACIN (PF) (amikacin sulfate/PF)
AMIKACIN SULFATE
AMIKACIN SULFATE
AMIKACIN SULFATE
AMIKACIN SULFATE
AMIKACIN SULFATE
AMIKACIN SULFATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonProteus meningitis is a severe, uncommon bacterial infection of the central nervous system characterized by inflammation of the meninges and spinal cord due to species of the gram-negative bacillary genus *Proteus*, most frequently *Proteus mirabilis*.
The condition predominantly affects neonates and infants through hematogenous seeding, though it can also occur in adults with risk factors such as prior neurosurgical intervention, cranial trauma, structural urinary tract disease, or immunocompromising conditions.
Pathophysiologically, it produces purulent cerebrospinal fluid pleocytosis, microvascular thrombosis, and severe tissue necrosis.
It is clinically distinguished by an aggressive acute course with high rates of intracranial complications, including cerebral abscess formation, ventriculitis, hydrocephalus, and lasting neurological deficits.
- nih.gov
Proteus meningitis is a severe, uncommon bacterial infection of the central nervous system characterized by inflammation of the meninges and spinal cord due to species of the gram-negative bacillary genus *Proteus*, most frequently *Proteus mirabilis* The condition predominantly affects neonates and infants through hematogenous seeding, though it can also occur in adults with risk factors such as prior neurosurgical intervention, cranial trauma, structural urinary tract disease, or immunocomprom...
- nih.gov
Proteus meningitis is a severe, uncommon bacterial infection of the central nervous system characterized by inflammation of the meninges and spinal cord due to species of the gram-negative bacillary genus *Proteus*, most frequently *Proteus mirabilis* The condition predominantly affects neonates and infants through hematogenous seeding, though it can also occur in adults with risk factors such as prior neurosurgical intervention, cranial trauma, structural urinary tract disease, or immunocomprom...
- nih.gov
The condition predominantly affects neonates and infants through hematogenous seeding, though it can also occur in adults with risk factors such as prior neurosurgical intervention, cranial trauma, structural urinary tract disease, or immunocompromising conditions It is clinically distinguished by an aggressive acute course with high rates of intracranial complications, including cerebral abscess formation, ventriculitis, hydrocephalus, and lasting neurological deficits
- nih.gov
Pathophysiologically, it produces purulent cerebrospinal fluid pleocytosis, microvascular thrombosis, and severe tissue necrosis It is clinically distinguished by an aggressive acute course with high rates of intracranial complications, including cerebral abscess formation, ventriculitis, hydrocephalus, and lasting neurological deficits
- jst.go.jp
It is clinically distinguished by an aggressive acute course with high rates of intracranial complications, including cerebral abscess formation, ventriculitis, hydrocephalus, and lasting neurological deficits
Personalize your experience
Follow Proteus meningitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.